Clinical Trials at University of South Florida
As of August 2026, 99 paid clinical trials are recruiting at University of South Florida, located at 3612 N ARLINGTON AVE, TAMPA, FL 33603-5606, phone (813) 221-5153 in Tampa, Florida. Active studies at this site cover conditions such as Breast Cancer, Heart Failure and Colorectal Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
View the full facility profile →
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Tampa
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
101 clinical trials at University of South Florida
·Clear filters·A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
The PREDICT Registry:
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Child and Adolescent Registry for Participants With Narcolepsy
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
Continuous Dual Aspiration Technique With Zoom System for Stroke
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Study of COYA 302 for the Treatment of ALS
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
Common conditions studied in Tampa
- Breast Cancer (22 active studies)
- Heart Failure (16 active studies)
- Colorectal Cancer (15 active studies)
- Acute Myeloid Leukemia (14 active studies)
- Cancer (13 active studies)
- Myelodysplastic Syndromes (12 active studies)
Leading research sponsors in Tampa
- H. Lee Moffitt Cancer Center and Research Institute
- University of South Florida
- AstraZeneca
- National Cancer Institute (NCI)
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Tampa?
There are approximately 1,055 recruiting clinical trials in Tampa, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tampa pay participants?
Most recruiting trials in Tampa compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tampa?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tampa?
The most common conditions under active study in Tampa include Breast Cancer (22), Heart Failure (16), Colorectal Cancer (15), Acute Myeloid Leukemia (14), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tampa?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tampa on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tampa?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tampa?
Recruiting research sites in Tampa include Moffitt Cancer Center, University of South Florida, Tampa General Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tampa right now?
The largest active categories in Tampa are Cancer & tumors (380), Neurology & pain (63), Cardiovascular (53). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of South Florida?
University of South Florida is located at 3612 N ARLINGTON AVE, TAMPA, FL 33603-5606. Use the Google Maps link in the intro above to get directions.
How do I contact University of South Florida?
You can reach University of South Florida by phone at (813) 221-5153. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.